Impact of the MonCœur smartphone application on self-care and quality of life in heart failure: The APPLIMONCOEUR randomized trial
Archives of Cardiovascular Diseases · 2026-10 · 119 (10) · 623-633
DOI: 10.1016/j.acvd.2026.04.007 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Archives of Cardiovascular Diseases, 2026-10. Verfasst von Emmanuelle Berthelot und 14 weiteren Autor:innen. Beteiligte Einrichtung: Service de Cardiologie, Hôpital Bicêtre, AP-HP, 94270 Le-Kremlin-Bicêtre, France; UMR S1358, INSERM, Université Paris-Saclay, 92350 Le-Plessis-Robins…. Hauptthemen laut MEDLINE: Quality of Life, Heart Failure, Self Care, Mobile Applications. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SFC.
Themen: Herzinsuffizienz, Selbstmanagement bei chronischen Erkrankungen
Abstract (Originalsprache)
BACKGROUND: The MonCœur smartphone application (app) was developed to meet the specific needs of individuals living with heart failure (HF). AIMS: To evaluate whether the MonCœur smartphone app improves self-care at 6months in patients with HF, and to assess effects on quality of life, physical activity and medication adherence. METHODS: APPLIMONCOEUR was a prospective, multicentre, randomized, controlled, open-label trial conducted in 12 HF centres in France. Adults with HF (left ventricular ejection fraction ≤40%) hospitalized for de novo or decompensated HF, or within 3months of discharge, were randomized 1:1 to usual care or usual care plus MonCœur mobile app. Follow-up occurred at baseline, 3, 6 (primary timepoint) and 12months. The primary endpoint was change in self-care (European Heart Failure Self-care Behaviour Scale [EHFSCB] score) at 6months. Secondary endpoints included health-related quality of life (Minnesota Living with Heart Failure Questionnaire [MLWHFQ] score), weekly physical activity (mins/week per World Health Organization categories) and medication adherence (Girerd questionnaire). Analyses were performed on the intention-to-treat population with multiple imputation; between-group differences at follow-up were assessed using analysis of covariance adjusted for baseline values. RESULTS: Among 123 randomized patients (control n=64; app n=59), baseline characteristics and therapies were well balanced. At 6months, no significant difference was found for self-care (EHFScB total P=0.23). Quality of life improved similarly in both groups (MLWHFQ total P=0.87). Physical activity increased in both groups, with no between-group differences at 6months (intensive P=0.92; moderate-to-intensive P=0.63), but exploratory 12-month analyses favoured the app (P=0.002 and P=0.008, respectively). Medication adherence increased modestly in both groups (P=0.12). Only 25/59 (42.4%) of app users were active (i.e. used the app at least 3 times during the study). CONCLUSION: The MonCœur randomized trial suggests that a mobile app dedicated to HF management may contribute to behavioural changes, particularly in physical activity, although patient engagement with the app was moderate. CLINICALTRIALS: GOV: NCT04198779.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service de Cardiologie, Hôpital Bicêtre, AP-HP, 94270 Le-Kremlin-Bicêtre, France; UMR S1358, INSERM, Université Paris-Saclay, 92350 Le-Plessis-Robinson, France. Electronic address: emmanuelle.berthelot@aphp.fr.
- Service de Cardiologie, Hôpital Henri-Mondor, Université Paris-Est Créteil, AP-HP, 94000 Créteil, France.
- University of Poitiers, Clinical Investigation Center (INSERM 1402), FACT and ACTION networks, University Hospital of Poitiers, Cardiology Department, 86021 Poitiers, France.
- Médipôle Hôpital Mutualiste, Service de Cardiologie, 69100 Lyon-Villeurbanne, France.
- Department of Cardiology, University Hospital, 38700 La Tronche, France.
- Unité Insuffisance Cardiaque, Assistance et Transplantation Cardiaque, Service de Cardiologie, CHU de Toulouse, Hôpital Rangueil, TSA 50032, 31059 Toulouse cedex 9, France.
Förderung
- SFC
Zitieren
APA
Berthelot, E., Audureau, E., Bouleti, C., Duval, A. J., Canu, M., Itier, R., Legrand, L., Alloujami, M., Tartiere, J. M., Degroote, P., Logeart, D., Roubille, F., Martin, A. C., Damy, T., & Bauer, F. (2026). Impact of the MonCœur smartphone application on self-care and quality of life in heart failure: The APPLIMONCOEUR randomized trial. Archives of Cardiovascular Diseases, 119(10), 623-633. https://doi.org/10.1016/j.acvd.2026.04.007
Vancouver
Berthelot E, Audureau E, Bouleti C, Duval AJ, Canu M, Itier R, et al. Impact of the MonCœur smartphone application on self-care and quality of life in heart failure: The APPLIMONCOEUR randomized trial. Archives of Cardiovascular Diseases. 2026;119(10):623-633. doi:10.1016/j.acvd.2026.04.007
BibTeX
@article{Berthelot2026,
author = {Berthelot, Emmanuelle and Audureau, Etienne and Bouleti, Claire and Duval, Antoine Jobbe and Canu, Marjorie and Itier, Romain and Legrand, Lise and Alloujami, Mazen and Tartiere, Jean-Michel and Degroote, Philippe and Logeart, Damien and Roubille, François and Martin, Anne-Céline and Damy, Thibaud and Bauer, Fabrice},
title = {Impact of the MonCœur smartphone application on self-care and quality of life in heart failure: The APPLIMONCOEUR randomized trial},
journal = {Archives of Cardiovascular Diseases},
year = {2026},
volume = {119},
number = {10},
pages = {623--633},
doi = {10.1016/j.acvd.2026.04.007}
}
EUVIMED